PU Yujie 1,2 , SONG Xiaohai 1,2 , Wadjaja Jason 1,2 , CAO Zhan 2 , YANG Shiqin 2 , LI Rouli 2 , DU Qiang 1,2 , WAN Qianyi 1,2 , ZHAO Rui 1,2 , ZHANG Guixiang 1 , CHENG Zhong 1 , CHEN Yi 1,2
  • 1. Division of Gastrointestinal Surgery, Department of General Surgery, West China Hospital, Sichuan University, Chengdu 610041, P. R. China;
  • 2. West China School of Medicine, Sichuan University, Chengdu 610041, P. R. China;
CHEN Yi, Email: toddy@scu.edu.cn
sleeve gastrectomy; single-incision plus one-port; bariatric surgery; reduced-port laparoscopic surgery; obesity
10.7507/1007-9424.202506017
Export PDF Favorites Scan Get Citation

Abstract Full text Figures/Tables References Cited by

Objective To evaluate the safety, feasibility, and efficacy of single-incision plus one-port laparoscopic sleeve gastrectomy (SILS+1) for patients with obesity. Methods A retrospective analysis was conducted on obese patients undergoing laparoscopic sleeve gastrectomy (LSG) from January 2023 to November 2024. Patients were stratified into two groups: SILS+1 and conventional multi-port LSG (MPLSG). Comparative parameters included operative time, postoperative hospital stay, complication rates, weight loss outcomes, and improvement in metabolic indicators [including hemoglobin A1c (HbA1c), triglyceride (TG), total cholesterol (TC), and high-density lipoprotein cholesterol (HDL-C)]. Results A total of 95 patients with obesity were enrolled, including 40 in the SILS+1 group and 55 in the MPLSG group. The SILS+1 group had significantly lower preoperative BMI, HbA1c, and TC levels compared to the MPLSG group (P<0.05), and a significantly higher proportion of female patients (P<0.05). Other baseline characteristics, such as age, TG, and HDL-C levels, showed no statistically significant differences (P>0.05). Operative time was significantly longer in the SILS+1 group than in the MPLSG group [(100.16 ± 17.53) min vs. (93.82 ± 20.83) min, P<0.001]. The proportion of patients requiring drainage tube placement was significantly lower in the SILS+1 group [55.0% (22/40) vs. 76.4% (42/55), P=0.049]. There were no statistically significant differences between the two groups in the need for additional trocar sites, change in Hb level from preoperative to postoperative day 1, postoperative hospital stay, or incidence of postoperative complications (Clavien-Dindo grade I) (P>0.05). No 30-day readmissions occurred in either group. One patient in the SILS+1 group required an additional trocar site. Gastrointestinal patency was normal in all patients, with no signs of contrast agent leakage or stricture observed. Both SILS+1 and MPLSG procedures demonstrated equivalent efficacy in weight loss outcomes (P>0.05) and in their effects on HbA1c, TG, and TC levels (P>0.05). The SILS+1 procedure showed a significant advantage in improving HDL-C levels (F=6.221, P=0.015), with significantly higher postoperative HDL-C levels observed at 6 months postoperatively compared to the MPLSG group (F=2.500, P=0.027). Conclusions For selected obese populations, SILS+1 represents a feasible and safe alternative to MPLSG. This technique demonstrates equivalent efficacy to MPLSG in early-stage weight loss and metabolic improvement, serving as a transitional approach toward pure single-incision laparoscopic sleeve gastrectomy.

Copyright © the editorial department of CHINESE JOURNAL OF BASES AND CLINICS IN GENERAL SURGERY of West China Medical Publisher. All rights reserved